Early Anticoagulation Within Two Weeks of Stroke Onset Shows Better Outcomes in AF Patients: Study Medha Baranwal15 April 2025 9:45 PM ISTUSA: A recent randomized clinical trial evaluating the optimal timing for initiating anticoagulation after an ischemic stroke in patients with atrial...
Asundexian May Offer Safer Stroke Prevention in AF Patients New to Blood Thinners: OCEANIC-AF Analysis Medha Baranwal14 April 2025 9:00 AM ISTUSA: A recent subgroup analysis from the OCEANIC-AF randomized clinical trial highlights that asundexian, a novel oral Factor XIa inhibitor, may offer...
Finerenone Shows Consistent Efficacy in Heart Failure Regardless of Atrial Fibrillation Status: Study Dr Riya Dave11 April 2025 8:15 AM ISTResearchers have discovered in a study published in JAMA Cardiology that finerenone offers stable benefits in heart failure (HF) patients with mildly...
Gasdermin D emerges as potential therapeutic target for atrial fibrillation, suggests study Dr. Kamal Kant Kohli10 April 2025 9:30 AM ISTAtrial fibrillation (AF) is a common form of heart arrhythmia, a serious condition in which the heart beats so fast that its upper chambers, the...
AF in midlife linked to 21% increased risk of dementia at any age and a 36% higher risk of early-onset dementia: Study Dr. Kamal Kant Kohli31 March 2025 9:00 PM ISTNew research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation...
Asundexian Shows Lower Stroke Risk in oral anticoagulant Naive Patients: JAMA Dr Riya Dave31 March 2025 11:00 AM ISTResearchers have found in a new study that oral anticoagulants OAC-naive patients experienced a smaller increase in stroke or systemic embolism with...
Optimized Linear Ablation with EIVOM Enhances Rhythm Control in Persistent Atrial Fibrillation: PROMPT-AF Trial Medha Baranwal6 March 2025 9:00 AM ISTChina: A recent randomized clinical trial, PROMPT-AF, has demonstrated that pulmonary vein isolation (PVI) combined with optimized linear ablation...
Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
JnJ to resume US VARIPULSE cases Ruchika Sharma20 Feb 2025 9:30 AM ISTNew Brunswick: Johnson & Johnson will resume the limited market release of VARIPULSE in the United States after a comprehensive...
Bleeding risk with apixaban and dabigatran similar to aspirin, suggests study Dr. Kamal Kant Kohli19 Feb 2025 8:00 AM ISTA systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs)...
Younger Stroke Patients with Atrial Fibrillation Face Increased Risks, Study Finds Medha Baranwal17 Feb 2025 9:15 PM ISTSpain: A two-decade cohort study published in the European Journal of Neurology has revealed a concerning association between atrial fibrillation (AF)...
Novartis to acquire Anthos Therapeutics for USD 925 million upfront, bolsters late-stage cardiovascular pipeline Ruchika Sharma11 Feb 2025 5:50 PM ISTBasel: Novartis today announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, privately held,...
